These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11117531)

  • 1. Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
    Hall JM; Chang CY; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2010-23. PubMed ID: 11117531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
    Chang Cy; Norris JD; Grøn H; Paige LA; Hamilton PT; Kenan DJ; Fowlkes D; McDonnell DP
    Mol Cell Biol; 1999 Dec; 19(12):8226-39. PubMed ID: 10567548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
    Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
    Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
    Huang HJ; Norris JD; McDonnell DP
    Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
    Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
    Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
    Bramlett KS; Wu Y; Burris TP
    Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser-884 adjacent to the LXXLL motif of coactivator TRBP defines selectivity for ERs and TRs.
    Ko L; Cardona GR; Iwasaki T; Bramlett KS; Burris TP; Chin WW
    Mol Endocrinol; 2002 Jan; 16(1):128-40. PubMed ID: 11773444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.
    Wong CW; Komm B; Cheskis BJ
    Biochemistry; 2001 Jun; 40(23):6756-65. PubMed ID: 11389589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
    Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
    Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide antagonists of the human estrogen receptor.
    Norris JD; Paige LA; Christensen DJ; Chang CY; Huacani MR; Fan D; Hamilton PT; Fowlkes DM; McDonnell DP
    Science; 1999 Jul; 285(5428):744-6. PubMed ID: 10426998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y; Giguére V
    Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
    Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
    Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tamoxifen-induced coregulator interaction surfaces within the ligand-binding domain of estrogen receptors.
    Heldring N; Nilsson M; Buehrer B; Treuter E; Gustafsson JA
    Mol Cell Biol; 2004 Apr; 24(8):3445-59. PubMed ID: 15060164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
    Hall JM; McDonnell DP; Korach KS
    Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha.
    Pettersson K; Grandien K; Kuiper GG; Gustafsson JA
    Mol Endocrinol; 1997 Sep; 11(10):1486-96. PubMed ID: 9280064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.